Microbiota, type 2 diabetes and non-alcoholic fatty liver disease: protocol of an observational study.

Benedetta Maria MottaChristoph GranderMartin GögeleLuisa FocoVladimir VukovicRoberto MelottiChristian FuchsbergerAlessandro De GrandiChiara CantaloniAnne PicardDeborah MascalzoniAlessandra RossiniCristian PattaroHerbert TilgPeter P Pramstaller

Published in: Journal of translational medicine (2019)

Given the comprehensive biochemical and clinical characterization of study participants, once the bioinformatics classification of the microbiota will be completed, the CHRIS-NAFLD study will become a useful resource to further our understanding of the relationship between microbiota, T2D and NAFLD.

Keyphrases

type diabetes
randomized controlled trial
machine learning
cardiovascular disease
glycemic control
skeletal muscle
weight loss